PCOS Is Now PMOS, What the Rename Means

It was a landmark global consensus study.

So just to highlight this again, that is a very rare thing to see.

We're talking about a global consensus across many different specialties and medical boards, essentially highlighting that PCOS, which again is polycystic ovarian syndrome, has officially been renamed.

So I want to kind of break this down for you a little bit in terms of like, what did the study actually highlight? So we had 22,000 clinicians and patients across basically 11 years of global consultation going through this kind of framing in terms of a survey to help us understand should we and ought we change the name from PCOS to something called PMOS.

So the new name, this is a mouthful, is polyendocrine metabolic ovarian syndrome.

So note a couple things there.

We got rid of cysts, polycystic.

We completely removed that word.

We got rid of more or less the idea of ovaries being the true highlighted factor here.

There's still a factor, but really what we're focusing on is two new words, endocrine and polyendocrine, meaning a variety of of hormonal disruptions with a metabolic process background, okay? So we've got a really interesting new framing here.

And I want to talk about why this even matters.

What does it mean? You know, because again, it can get really confusing.

We've been saying PCOS for decades now, right? And our patients even know what that is.

Most women, if you kind of just toss that acronym out there, they'll probably pick up on what that is.

And certainly, most providers will.

So making a name change is a massive disruption.

Again, we're going to have about three years, and I'll get to that in a moment here, to kind of come to terms with moving away from saying or using PCOS and now saying PMOS.

But this community, as far as the HRT University family goes, again, we've understood this.